68,15242,019Total current liabilities
203,04486,675Long-term liabilities: Long-term other liabilities
215,45793,108Stockholders' equity Preferred stock, $0.001 par value; authorized: 5,000,000 shares; no shares issuedand outstanding.
--Common stock, $0.001 par value; authorized: 100,000,000 shares; issued: 72,199,837 and 60,666,974 shares at June 30, 2011 and 2010, respectively; outstanding: 70,059,819 and 58,526,956 shares at June 30, 2011 and 2010, respectively.
7059Additional paid-in capital
373,963287,764Accumulated other comprehensive income (loss)
(144,385)(117,676)Total stockholders' equity
240,327170,076Total liabilities and stockholders' equity
$455,784$263,184Non-GAAP Financial MeasuresThis press release includes non-GAAP financial measures, as defined in Regulation G promulgated by the Securities and Exchange Commission, with respect to the three months ended June 30, 2011. "GAAP" refers to generally accepted accounting principles in the United States.
Accuray closed the acquisition of TomoTherapy on June 10, 2011 and TomoTherapy's operations since that date are included in Accuray's consolidated results of operations. Accounting for the impact of this acquisition has resulted in changes to the value of assets and liabilities from the amounts reflected by TomoTherapy prior to the acquisition and the creation of incremental assets and liabilities including intangible assets for developed technology and backlog, and unfavorable lease obligations. These changes have impacted revenues and expenses recorded in Accuray's consolidated statement of operations since the clo
|SOURCE Accuray Incorporated|
Copyright©2010 PR Newswire.
All rights reserved